Dietary Fat Reduction Improves Long-Term Survival in ER-negative Breast Cancers
Reducing dietary fat intake appears to improve survival rates among women with certain types of breast cancer.
SABCS 2014
Adding Bortezomib to Fulvestrant Might Improve Outcomes for ER+ Metastatic Breast Cancer
Targeting the proteasome might help prevent breast tumor resistance to endocrine therapy.
Adding Everolimus to Trastuzumab, Paclitaxel Does Not Prolong Survival
Adding everolimus to paclitaxel, trastuzumab does not significantly prolong progression-free survival (PFS) in breast cancer.
Disappointing Results for Dual Anti-HER2 Therapy Without Chemotherapy
Extending duration of dual anti-HER2 therapy without chemotherapy did not significantly improve molecular response in HER2-positive breast tumors.
Ultrasound Breast Screenings Improve Tumor Detection in Women with Dense Breast Tissue
Ultrasound breast screenings for women with dense breast tissue improves cancer detection.
DCIS Score Predicts Recurrence after Breast-Conserving Surgery
The Oncotype DX DCIS Score accurately predicts recurrence risk for patients treated with breast-conserving surgery (BCS).
Accelerated Partial Breast Radiotherapy Improves Toxicity, Doesn’t Reduce Local Recurrence
Accelerated partial breast irradiation (APBI) using intensity-modulation radiotherapy (IMRT) does not reduce local breast cancer recurrence.
Adding Ovarian Function Suppression to Tamoxifen Can Worsen Endocrine, Sexual Symptoms, Quality of Life
Adding ovarian function suppression (OFS) is associated with several patient-reported endocrine symptoms and impacts sexual functioning.
Ovarian Suppression Improves Prevention of HR-Positive Breast Cancer Recurrence
Adding ovarian function suppression (OFS) to adjuvant postsurgical tamoxifen therapy can reduce breast cancer recurrence.
Long-Term Chemoprevention Trial Follow-up Confirms Tamoxifen Lowers Rates in High-Risk Women
Tamoxifen significantly reduces breast cancer incidence among women at high risk for breast cancer.
Want to read more?
Please login or register first to view this content.
